Growth Opportunities in HPV Testing and Pap Test Market

The HPV test is used to diagnose the infection caused by HPV that mutates a normal cell into a cancerous cell and further leads to the development of genital warts, abnormal cervical cells, or cervical cancer. The growth of the HPV testing and Pap test market is mainly attributed to the increasing number of cervical cancer cases, growing the aging population, increasing awareness of cervical cancer screening programs, and government initiatives and funding

According to Latest Market research report Published by MarketsandMarkets the “HPV Testing and Pap Test Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach $ 4.52 billion, at a CAGR of 6.6%

key players operating in the Global HPV Testing and Pap Test Market;

Key players in the market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.)

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371

Major Dynamics Impacting the HPV Testing and Pap Test Market;

· Growth Drivers:

1. An increasing number of cervical cancer cases and a growing aging population

2. Increasing awareness of cervical cancer screening programs

3. Government initiatives and funding.

· Restraints

1. Changes in regulatory guidelines for cervical cancer screening
2. HPV vaccination

Objectives of The Study-

• To define, describe, and segment the global HPV testing and Pap test market on the basis of test types, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the global HPV testing and Pap test market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371

Global HPV Testing and Pap Test Market Segmentation:

Based on the application, the Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is expected to grow at the highest CAGR during the forecast period, owing to the growing incidences of cervical cancer.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to grow at the highest CAGR in the forecast period. Increased government funding & grants and introduction of HPV primary tests are major factors fueling the growth of the HPV testing and Pap test market in North America.

HPV Testing and Pap Test Market: Worldwide Industry Analysis and New Market Opportunities Explored

The report “HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End-User (Laboratories, Hospitals, Physicians’ Offices & Clinics) — Global Forecast”, published by MarketsandMarkets™

Cervical cancer is the second most common type of cancer in women, preceded by breast cancer. HPV, a sexually transmitted virus, has been clinically proven to be the primary cause of cervical cancer. HPV contributes to around 90% of all anal and cervical cancers and 70% of vaginal and vulvar cancers. Pap tests are the most preferred tests to detect cervical cancer. These tests include microscopic observation of specimens.

The HPV testing and Pap test Market is poised to reach USD 4,523.1 Million, at a CAGR of 6.6%

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371

The increasing number of cervical cancer cases and the growing aging population

Cervical cancer is considered to be the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012. This figure is expected to reach to 609,270 new cases and 315,727 deaths by 2020. (Source: Globocan 2012). Approximately 26,000 new cancers attributable to HPV occur each year, 18,000 among females and 8,000 among males (Source: CDC). The growing number of cervical cancer cases results in the need for new, technically advanced, and less expensive screening programs. This, in turn is expected to drive the HPV testing and Pap test market in the coming years.

HPV Testing and Pap Test Market Drivers:

• The increasing number of cervical cancer cases and a growing aging population
• Increasing awareness of cervical cancer screening programs
• Government initiatives and funding.

Geographic Analysis:

• Detailed analysis of HPV testing and Pap test market in European countries such as the UK, Germany, France, Italy, Spain, and others

Geographically, the HPV testing and Pap test market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to grow at the highest CAGR in the forecast period. Increased government funding & grants and introduction of HPV primary tests are major factors fueling the growth of the HPV testing and Pap test market in North America.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371

Key players in the HPV testing and Pap test market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.). These players focus on inorganic and organic strategies such as product approvals & licenses, agreements, collaborations, and partnerships, expansions, acquisitions to sustain their growth in the HPV testing and Pap test market.

HPV Testing and Pap Test Market: Opportunities, Countries, Type, Application Technologies, Development Challenges and Forecast 2019

The Research Report on HPV Testing & Pap Test Market provides a detailed overview of major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.

Several factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.

Download PDF (HPV Testing & Pap Test Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

This research report segments the HPV Testing & Pap Test Market based on by test type, application, end user, and region.

An increasing number of cervical cancer cases and a growing aging population

Cervical cancer is the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012. This figure is expected to reach to 609,270 new cases and 315,727 deaths by 2020.

Approximately 26,000 new cancers attributable to HPV occur each year, 18,000 among females and 8,000 among males (Source: CDC). The growing number of cervical cancer cases results in the need for new, technically advanced, and less expensive screening programs. This, in turn, is expected to drive the HPV testing and Pap test market in the coming years.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371

HPV Testing & Pap Test Market Based on Application;

Based on the application, the Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is expected to grow at the highest CAGR during the forecast period, owing to the growing incidences of cervical cancer.

Global HPV testing and Pap test Market, by Region

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

HPV Testing & Pap Test Market Based on end user;

On the basis of end user, the HPV testing and Pap test market is categorized into hospitals, laboratories, physician’s offices and clinics. The hospitals segment is projected to grow at the highest CAGR. This growth is attributed to the increasing patient volumes in hospitals, as most diagnostic tests are carried out in-house with advanced technologies and more accessibility.

Speak to Our Subject Expert:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=214207371

HPV Testing & Pap Test Market’s Major Key Players:

Key players in the HPV testing and Pap test market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.).

HPV testing and Pap test Market 2019 – Global Industry Size, Share, Analysis, Trend & Future Strategic Planning

The Global HPV Testing & Pap Test Market is projected to reach the US $ 4.52 billion, at a CAGR of 6.6%

The Research report provides a detailed overview of Several factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.

Download PDF (HPV Testing and Pap Test Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371

the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.

The increasing number of cervical cancer cases and the ing aging population

Cervical cancer is considered to be the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012.

HPV Testing & Pap Test Market segmentation:

· based on products

· based on diseases

· based on techniques,

· based on end users

· based on regions.

The Major Players Operating in the HPV Testing & Pap Test Market:

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson, and Company (U.S.) are the key players operating in the HPV testing and Pap test market.

Speak to Our Subject Expert (HPV Testing and Pap Test Market):

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=214207371

Major Developments in HPV Testing & Pap Test Market

• In April 2014, Roche received the U.S. FDA approval for its cobas HPV (Human Papillomavirus) Test, which is used as a first-line primary screening test for cervical cancer in women.
• In February 2014, BD Diagnostics received the CE/IVD marking for the BD Onclarity HPV Assay that can be used on the new BD Viper LT System
• In September 2015, QIAGEN introduced careHPV Test and digene HC2 Collection Device for the HPV screening process in women.
• IN February 2014, QIAGEN expanded commercial launch of careHPV test in India, a molecular diagnostic test for high risk human papillomavirus (HPV), a primary cause of cervical cancer in woman.

Geographical Detailed Analysis for HPV Testing & Pap Test Market:

Geographically, the HPV testing and Pap test market are segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

North America is expected to grow at the highest CAGR in the forecast period. Increased government funding & grants and an introduction of HPV primary tests are major factors fueling the growth of the HPV testing and Pap test market in North America.

Request Research Sample Pages (HPV Testing & Pap Test Market):

https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371